Byotrol PLC EPA Approval (8664H)
13 Giugno 2017 - 8:00AM
UK Regulatory
TIDMBYOT
RNS Number : 8664H
Byotrol PLC
13 June 2017
Byotrol Plc
("Byotrol" or the "Company")
APPROVAL RECEIVED FROM U.S. ENVIRONMENTAL PROTECTION AGENCY
("EPA")
FOR LONG-LASTING ANTI-MICROBIAL PRODUCT
Byotrol plc, the specialist anti-microbial technology company,
is pleased to announce that the US EPA has formally approved
Byotrol's proprietary 24-hour germ-kill surface sanitizer for sale
in the US (EPA Reg. Number 83614-1).
The formulation has been under development at Byotrol for over
seven years and the Directors believe offers unique performance
characteristics to US consumers and businesses.
To US consumers our products will be able to claim high
performance cleaning and viricidal action, plus long-lasting
benefits such as:
-- 24-hour surface protection against bacteria
-- Scientifically proven to kill >99.9% of bacteria for 24 hours
-- 7 day mold and mildew prevention
-- Eliminates >99.9% of viruses
The Directors are not aware of any other cleaning or sanitizing
products that can make such claims for US consumers; we believe
this approval gives Byotrol a unique opportunity in the substantial
US market.
To US businesses, the formulation will be positioned to offer
cost-benefits, such as higher infection control for less chemical
use and decreased absenteeism from work.
The EPA has specifically approved the product's use (and the
24-hour claim) in domestic households, travel and leisure,
janitorial and sanitation environments, pet and vet environments
and all non-food contact surfaces. The product has also been
approved for use as a surface sanitizer in hospital
environments.
The Company has been exploring alliances and commercial
opportunities with various US organisations since the
application was made to the EPA. Today's approval allows us to accelerate these discussions.
David Traynor, Chief Executive of Byotrol plc comments:
"We are very excited to gain this registration. This project is
one of 3 core R&D initiatives in the Company, so its successful
conclusion is a very significant moment for us.
We are not aware of any product in the US market that can make
competing 24-hour germ-kill claims, yet we are very confident that
such claims are valued by both consumers and business users in
markets that we estimate in retail alone total over US$1bn."
Enquiries:
Byotrol plc 01925 742 000
David Traynor - Chief Executive
finnCap Ltd 020 7220 0500
(Nominated Adviser & Broker)
Geoff Nash/Carl Holmes/James Thompson - Corporate Finance
The information communicated in this announcement contains
inside information for the purposes of Article 7 of the Market
Abuse Regulation (EU) No. 596/2014.
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer
of residual antimicrobial technologies,
identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.
Our patented suite of technologies deliver powerful
broad-spectrum efficacy with residual performance
optimised against commonly occurring and industry-specific pathogens
Founded in 2005, the Company has developed the technology that
creates easier, safer and cleaner lives
For more information, please go to www.byotrol.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSFIFMEFWSEDM
(END) Dow Jones Newswires
June 13, 2017 02:00 ET (06:00 GMT)
Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Lug 2024 a Ago 2024
Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Ago 2023 a Ago 2024